Fundz

Antiverse raised £3.5M ($4.6M) in seed funding led by i&i Biotech Fund I and Kadmos Capital to advance its generative AI antibody design platform.

PRIVATEOct 15, 2024

Amount Raised

£3.5 Million

Round Type

Seed

CardiffBiotechnologyHealth CareTherapeutics

Investors

Kadmos CapitalUki2 SI&I Biotech Fund IAngelHubInnospark VenturesTensor Ventures

Description

Antiverse, a techbio company, has added £3.5M ($4.6M) to its seed funding. This investment will support the company's growth and development of its antibody design programs, including plans to expand its laboratory and machine learning teams.

Quick answer

Antiverse raised £3.5 Million in a Seed round, dated October 15, 2024. Investors: Kadmos Capital, Uki2 S, I&I Biotech Fund I, AngelHub, Innospark Ventures and Tensor Ventures. Antiverse is based in Cardiff, Wales, United Kingdom.

How much did Antiverse raise?
Antiverse raised £3.5 Million in a Seed round on October 15, 2024.
Who invested in Antiverse?
Kadmos Capital, Uki2 S, I&I Biotech Fund I, AngelHub, Innospark Ventures and Tensor Ventures are named as investors in this round.
What does Antiverse do?
Antiverse is a techbio company focused on designing antibodies for challenging targets using a machine-learning-centered approach.
Where is Antiverse based and how big is it?
Antiverse is based in Cardiff, Wales, United Kingdom. Fundz records about 17 employees.
Who are the decision-makers at Antiverse?
Fundz holds 1 contact at Antiverse. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Antiverse that raised within 45 days of this round, from Fundz verified event records.

  • Celosia Therapeutics raised $17M (Series A) on November 28, 2024.
  • Intensity Therapeutics raised $3.6M (Seed) on November 21, 2024.
  • Biofrontera raised $4.2M (Seed) on November 21, 2024.
  • Debiopharm raised $5.8M (Funding Round) on November 21, 2024.
  • HCW Biologics raised $6.9M on November 20, 2024.
  • Adipo Therapeutics raised $4.7M (Seed) on November 19, 2024.

Who to call at Antiverse, and when

A new round usually means Antiverse is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Antiverse raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Antiverse, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Antiverse. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Antiverse

Location

Cardiff, Wales, United Kingdom

About

Antiverse is a techbio company focused on designing antibodies for challenging targets using a machine-learning-centered approach. Their platform enhances predictive accuracy by utilizing target-specific libraries generated from structural and sequence data. Antiverse aims to accelerate the antibody discovery process, making difficult targets druggable and bringing vital therapies to patients. The company is actively expanding its team and facilities to support its growth and research initiatives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Antiverse raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Antiverse's next move

See what Strategic adds

Antiverse raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.